MARC Record from marc_columbia

LEADER: 06235cam a22004694a 4500
001 6350252
005 20221122024643.0
008 061121t20072007njua b 001 0 eng
010 $a 2006038697
015 $aGBA714620$2bnb
016 7 $a101293303$2DNLM
016 7 $a013678495$2Uk
020 $a9781588298188 (alk. paper)
020 $a1588298183 (alk. paper)
029 1 $aNLM$b101293303
035 $a(OCoLC)ocm76794791
035 $a(OCoLC)76794791
035 $a(NNC)6350252
035 $a6350252
040 $aDNLM/DLC$cDLC$dNLM$dBTCTA$dUKM$dBAKER$dC#P$dYDXCP$dOrLoB-B
042 $apcc
050 00 $aRC846$b.L553 2007
060 10 $aWI 700$bL783459 2007
082 00 $a616.3/62079$222
245 00 $aLiver immunology :$bprinciples and practice /$cedited by M. Eric Gershwin, John M. Vierling and Michael P. Manns.
260 $aTotowa, N.J. :$bHumana Press,$c[2007], ©2007.
300 $axv, 486 pages :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $tForeword: Contemporary Liver Immunology and Immunopathology: Obstacles and Opportunities /$rIan R. Mackay -- $g1.$tA Short Primer on Fundamental Immunology /$rCliona O'Farrelly and Derek G. Doherty -- $g2.$tRole and Function of Liver Sinusoidal Endothelial Cells /$rPercy A. Knolle -- $g3.$tInnate Immune Mechanisms in the Liver /$rCliona O'Farrelly and Derek G. Doherty -- $g4.$tAntigen Processing and Presentation in the Liver /$rMasanori Abe and Angus W. Thomson -- $g5.$tAdaptive Immunity in the Liver /$rJames D. Gorham -- $g6.$tHepatic NK, NKT, and T Cells /$rGolo Ahlenstiel and Barbara Rehermann -- $g7.$tCytokines in Liver Health and Disease /$rPietro Invernizzi, Ilaria Bianchi, Massimo Locati, Raffaella Bonecchi and Carlo Selmi -- $g8.$tPrevalence and Significance of Autoantibodies in Acute and Chronic Liver Diseases and Hepatocellular Carcinoma /$rChristian P. Strassburg and Michael P. Manns -- $g9.$tThe Role of Inflammation and Immunity in the Pathogenesis of Liver Fibrosis /$rWajahat Z. Mehal and Scott L. Friedman -- $g10.$tClinical Use of Immunopathology Techniques in Liver Diseases /$rChen Liu and James M. Crawford -- $g11.$tTumor Immunology: Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Neoplasms /$rChristopher L. Bowlus -- $g12.$tInnate and Adaptive Immune Responses to Bacterial and Parasite Infections: Clinicopathological Consequences /$rValentina Medici, Lorenzo Rossaro, Sripriya Balasubramanian and Stuart H. Cohen -- $g13.$tImmune Response to Hepatitis A and E Viruses: Role in Disease Pathogenesis unci Viral Elimination /$rJohannes Hadem and Michael P. Manns -- $g14.$tRole of the Immune Response in Hepatitis B: Determinants of Severity, Chronicity, and Response to Antiviral Therapy /$rAntonio Bertoletti, Patrick Kennedy and Adam J. Gehring -- $g15.$tImmune Responses in Acute and Chronic Hepatitis C: Implications for Prognosis and Therapy /$rHeiner Wedemeyer, Markus Cornberg and Michael P. Manns -- $g16.$tImmununopathogenesis of Extrahepatic Manifestations in HAV, HBV, and HCV Infections: Importance of Recognition and Therapy /$rSven Pischke, Arndt Vogel, Elmar Jaeckel and Michael P. Manns -- $g17.$tImmunogenetics of Autoimmune Liver Disease: Risk factors for Susceptibility and Progression /$rPeter Tickell Donaldson -- $g18.$tPrimary Biliary Cirrhosis and Autoimmune Cholangitis /$rCarlo Selmi, Ana Lleo, Pietro Invernizzi and M. Eric Gershwin -- $g19.$tSclerosing Cholangitis: Primary and Secondary /$rSue Cullen and Roger Chapman -- $g20.$tAutoimmune Hepatitis /$rDiego Vergani and Giorgina Mieli-Vergani -- $g21.$tUnique Aspects of Autoimmune Hepatitis in Children /$rGiorgina Mieli-Vergani and Diego Vergani -- $g22.$tOverlap Syndromes of Autoimmune Hepatitis With Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis /$rUlrich Beuers and Christian Rust -- $g23.$tAnimal Models of Autoimmune Liver Diseases /$rMarkus Biburger and Gisa Tiegs -- $g24.$tThe Immune Response in the Pathogenesis of Alcoholic Liver Disease /$rLynell W. Klassen and Geoffrey M. Thiele -- $g25.$tImmunomodulation Therapy for Alcoholic Hepatitis: Rationale and Efficacy /$rRobert O'Shea and Arthur J. McCullough -- $g26.$tRole of Immune Response in Nonalcoholic Fatty Liver Disease: Evidence in Human and Animal Studies /$rLiu Yang and Anna Mae Diehl -- $g27.$tMechanisms of Acute Liver Failure /$rChristian Trautwein and Alexander Koch -- $g28.$tImmune Mechanisms in Drug-Induced Hepatotoxicity: Therapeutic Implications /$rZhang-Xu Liu and Neil Kaplowitz -- $g29.$tAcute and Chronic Liver Diseases Induced by Drugs or Xenobiotics /$rFrank N. A. M. van Pelt, Michelle A. Carey and John B. Carey -- $g30.$tClinical Use of Immunosuppressive Drugs to Control the Immune Response /$rJohn M. Vierling -- $g31.$tHepatic Complications of Hematopoietic Cell Transplantation /$rHoward M. Shulman and George B. McDonald -- $g32.$tAcute and Chronic Rejection of the Liver Allograft /$rJames Neuberger -- $g33.$tImmunological Tolerance in Allo- and Xenografts /$rAftab A. Ansari and Kovit Pattanapanyasat -- $g34.$tAutoimmune Diseases in Transplanted Livers /$rHiromi Ishibashi, Shinji Shimoda, Minoru Nakamura and M. Eric Gershwin -- $g35.$tImmunopathogenesis and Outcomes of Recurrent Hepatitis C /$rJames R. Burton, Jr., Lucy Golden-Mason and Hugo R. Rosen.
650 0 $aLiver$xDiseases$xImmunological aspects.
650 0 $aLiver$xImmunology.
650 12 $aLiver$ximmunology.$0https://id.nlm.nih.gov/mesh/D008099Q000276
650 12 $aLiver$xpathology.$0https://id.nlm.nih.gov/mesh/D008099Q000473
650 22 $aAutoimmunity$ximmunology.$0https://id.nlm.nih.gov/mesh/D015551Q000276
650 22 $aLiver Diseases$ximmunology.$0https://id.nlm.nih.gov/mesh/D008107Q000276
700 1 $aGershwin, M. Eric,$d1946-$0http://id.loc.gov/authorities/names/n78049486
700 1 $aVierling, John M.$0http://id.loc.gov/authorities/names/no2002114062
700 1 $aManns, Michael P.$q(Michael Peter)$0http://id.loc.gov/authorities/names/no2002114063
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip075/2006038697.html
852 00 $boff,hsl$hRC846$i.L553 2007 Q